Skip to content
healthcare.dev

Naproxen Sodium

NDC 50228-432, Naproxen Sodium, tablet, from ScieGen Pharmaceuticals, Inc..

Product NDC
50228-432
Status
Listed
Labeler
ScieGen Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212199
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-432 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPROXEN SODIUM275 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
50228-432-0150228043201100 TABLET in 1 BOTTLE (50228-432-01)
50228-432-0550228043205500 TABLET in 1 BOTTLE (50228-432-05)
50228-432-10502280432101000 TABLET in 1 BOTTLE (50228-432-10)
50228-432-305022804323030 TABLET in 1 BOTTLE (50228-432-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/79f48c92-783d-40f2-9865-89958a9f9de6
  • NADAC price for package 50228043201

    GET /v1/drugs/nadac/50228043201
  • NADAC price for package 50228043205

    GET /v1/drugs/nadac/50228043205

Use it

Look up 50228-432 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-432 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-432. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.